{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:01:26Z","timestamp":1792119686152,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA134368"],"award-info":[{"award-number":["R21CA134368"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R33CA160138"],"award-info":[{"award-number":["R33CA160138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA199487"],"award-info":[{"award-number":["R03CA199487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA206980"],"award-info":[{"award-number":["P01CA206980"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES010126"],"award-info":[{"award-number":["P30ES010126"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LCCC Bioinformatics Core"},{"name":"University Cancer Research"},{"DOI":"10.13039\/100006279","name":"SJM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jid.2018.11.024","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T12:55:02Z","timestamp":1544100902000},"page":"1349-1361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis"],"prefix":"10.1016","volume":"139","author":[{"given":"Kathleen","family":"Conway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon N.","family":"Edmiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Fen","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Groben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Zedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glynis A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise A.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle V.","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig C.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios J.","family":"Moschos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ollila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.11.024_bib1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/jid.2010.61","article-title":"Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis","volume":"130","author":"Alexandrescu","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2217\/epi.10.16","article-title":"DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status","volume":"2","author":"Arai","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.jid.2018.11.024_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib5","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/onc.2009.150","article-title":"Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification","volume":"28","author":"Baras","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2018.11.024_bib6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/labinvest.2011.70","article-title":"Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury","volume":"91","author":"Baras","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.jid.2018.11.024_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2018.11.024_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/path.1061","article-title":"Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions","volume":"196","author":"Brochez","year":"2002","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.semdp.2013.11.002","article-title":"Molecular pathology of melanocytic tumors","volume":"30","author":"Busam","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2018.11.024_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/cdd.2015.100","article-title":"Kremen1 and Dickkopf1 control cell survival in a Wnt-independent manner","volume":"23","author":"Causeret","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jid.2018.11.024_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11523-017-0549-7","article-title":"Immune checkpoint blockade: the new frontier in cancer treatment","volume":"13","author":"Clarke","year":"2018","journal-title":"Target Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1755-148X.2011.00828.x","article-title":"DNA-methylation profiling distinguishes malignant melanomas from benign nevi","volume":"24","author":"Conway","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"issue":"12","key":"10.1016\/j.jid.2018.11.024_bib17","doi-asserted-by":"crossref","first-page":"e84225","DOI":"10.1371\/journal.pone.0084225","article-title":"Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions","volume":"8","author":"Dietrich","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.11.024_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fonc.2013.00252","article-title":"Melanoma biomolecules: independently identified but functionally intertwined","volume":"3","author":"Dye","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib19","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2018.11.024_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0046-8177(96)90157-4","article-title":"Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists","volume":"27","author":"Farmer","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/archderm.139.10.1374","article-title":"Terminology and management of dysplastic nevi: responses from 145 dermatologists","volume":"139","author":"Fung","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1349-7006.2004.tb03184.x","article-title":"Promoter methylation profiling of 30 genes in human malignant melanoma","volume":"95","author":"Furuta","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2018.11.024_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4161\/cc.23517","article-title":"Prognostic value of LIPC in non-small cell lung carcinoma","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jid.2018.11.024_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10238-014-0320-7","article-title":"Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer","volume":"15","author":"Gao","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jid.2018.11.024_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/pcmr.12096","article-title":"Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma","volume":"26","author":"Gao","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2018.11.024_bib26","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1038\/jid.2014.270","article-title":"Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy","volume":"134","author":"Gao","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/PAS.0000000000000198","article-title":"Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up","volume":"38","author":"Gerami","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib29","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":"The gene expression signatures of melanoma progression","volume":"102","author":"Haqq","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.11.024_bib30","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.11.024_bib31","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S1470-2045(16)30366-7","article-title":"Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial","volume":"17","author":"Hodi","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib32","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/sj.onc.1207505","article-title":"Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients","volume":"23","author":"Hoon","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2018.11.024_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nature Protoc"},{"key":"10.1016\/j.jid.2018.11.024_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/fon.10.81","article-title":"Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls","volume":"6","author":"Ivan","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib34","first-page":"157","article-title":"Loss of ONECUT1 expression in human pancreatic cancer cells","volume":"19","author":"Jiang","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jid.2018.11.024_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygeno.2015.09.004","article-title":"The DNA methylation landscape of human melanoma","volume":"106","author":"Jin","year":"2015","journal-title":"Genomics"},{"issue":"11","key":"10.1016\/j.jid.2018.11.024_bib36","doi-asserted-by":"crossref","first-page":"e1001551","DOI":"10.1371\/journal.pmed.1001551","article-title":"Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development","volume":"10","author":"Jones","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jid.2018.11.024_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fgene.2013.00271","article-title":"Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF\/RAS mutation","volume":"4","author":"Kikuchi","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.jid.2018.11.024_bib38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-16-0958","article-title":"Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes","volume":"26","author":"Ko","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jid.2018.11.024_bib39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/modpathol.2009.8","article-title":"Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue","volume":"22","author":"Koh","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2018.11.024_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992\u20132013","volume":"76","author":"Landow","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib42","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2015.200","article-title":"The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching","volume":"135","author":"Lessard","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib43","first-page":"1635","article-title":"OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling","volume":"5","author":"Li","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jid.2018.11.024_bib44","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdx176","article-title":"Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study","volume":"28","author":"Long","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib45","first-page":"673","article-title":"Aberrant expression of HOX genes in human invasive breast carcinoma","volume":"13","author":"Makiyama","year":"2005","journal-title":"Oncol Rep"},{"issue":"2\u20133","key":"10.1016\/j.jid.2018.11.024_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10409230902755056","article-title":"PAX3 across the spectrum: from melanoblast to melanoma","volume":"44","author":"Medic","year":"2009","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.jid.2018.11.024_bib47","doi-asserted-by":"crossref","first-page":"e9977","DOI":"10.1371\/journal.pone.0009977","article-title":"PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas)","volume":"5","author":"Medic","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.11.024_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/bdrc.21074","article-title":"Neural crest cells: from developmental biology to clinical interventions","volume":"102","author":"Noisa","year":"2014","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.jid.2018.11.024_bib49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/PAS.0000000000000189","article-title":"Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases","volume":"38","author":"North","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib50","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/hmg\/11.20.2479","article-title":"Cancer epigenomics","volume":"11","author":"Plass","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2018.11.024_bib51","first-page":"6589","article-title":"Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib52","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of pembrolizumab with tumor response and survival among patients with advanced melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2018.11.024_bib53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.11.024_bib55","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-14-3613","article-title":"CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus","volume":"75","author":"Russell","year":"2015","journal-title":"Cancer Res"},{"issue":"10105","key":"10.1016\/j.jid.2018.11.024_bib56","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","article-title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","volume":"390","author":"Schachter","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.11.024_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13148-016-0267-5","article-title":"SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas","volume":"8","author":"Semaan","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.jid.2018.11.024_bib58","doi-asserted-by":"crossref","first-page":"djv294","DOI":"10.1093\/jnci\/djv294","article-title":"Melanoma thickness and survival trends in the United States, 1989 to 2009","volume":"108","author":"Shaikh","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2018.11.024_bib59","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jid.2018.11.024_bib60","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jss.2010.03.043","article-title":"Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease","volume":"163","author":"Sharma","year":"2010","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jid.2018.11.024_bib61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2009.09.043","article-title":"Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center","volume":"62","author":"Shoo","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib62","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jid.2018.11.024_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40291-015-0144-5","article-title":"Diagnosis of lung cancer by SHOX2 gene methylation assay","volume":"19","author":"Song","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jid.2018.11.024_bib64","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2007.08136.x","article-title":"A\u00a0retrospective study addressed to understanding what predicts severe histological dysplasia\/early melanoma in excised atypical melanocytic lesions","volume":"157","author":"Strauss","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib65","first-page":"727","article-title":"Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer","volume":"39","author":"Tada","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2018.11.024_bib66","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":"Novel genes associated with malignant melanoma but not benign melanocytic lesions","volume":"11","author":"Talantov","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.11.024_bib67","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.0022-202X.2004.22523.x","article-title":"Tandem BRAF mutations in primary invasive melanomas","volume":"122","author":"Thomas","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1055-9965.EPI-06-1038","article-title":"Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma","volume":"16","author":"Thomas","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jid.2018.11.024_bib69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/pcmr.12289","article-title":"DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features","volume":"27","author":"Thomas","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2018.11.024_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A\u00a0p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<266::AID-PATH812>3.0.CO;2-#","article-title":"Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party","volume":"182","author":"Veenhuizen","year":"1997","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2018.11.024_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (\u22641 mm) than from thick melanomas (>4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.11.024_bib73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/gcc.10030","article-title":"Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma","volume":"33","author":"Wimmer","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jid.2018.11.024_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12916-017-0851-3","article-title":"Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma","volume":"15","author":"Wouters","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jid.2018.11.024_bib75","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.4238\/2015.May.4.11","article-title":"Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer","volume":"14","author":"Xing","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jid.2018.11.024_bib76","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1038\/onc.2010.370","article-title":"Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer","volume":"29","author":"Yu","year":"2010","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.jid.2018.11.024_bib77","doi-asserted-by":"crossref","first-page":"e40728","DOI":"10.1371\/journal.pone.0040728","article-title":"Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation","volume":"7","author":"Zha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.11.024_bib78","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3892\/ol.2013.1161","article-title":"Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer","volume":"5","author":"Zhao","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jid.2018.11.024_bib79","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3892\/ol.2015.3515","article-title":"High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinoma","volume":"10","author":"Zheng","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jid.2018.11.024_bib80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1515\/cclm-2013-0736","article-title":"Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival","volume":"52","author":"Zhou","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jid.2018.11.024_bib81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mvr.2015.12.001","article-title":"Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in\u00a0vivo","volume":"104","author":"Zimmerer","year":"2016","journal-title":"Microvasc Res"},{"issue":"Pt. 2","key":"10.1016\/j.jid.2018.11.024_bib82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the Elastic Net","volume":"67","author":"Zou","year":"2005","journal-title":"J\u00a0R Stat Soc Series B Stat Methodol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18329166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18329166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:15:28Z","timestamp":1758302128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18329166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0022202X18329166"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.11.024","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}